Table of Contents Author Guidelines Submit a Manuscript
TheScientificWorldJOURNAL
Volume 5, Pages 652-660
http://dx.doi.org/10.1100/tsw.2005.86
Research Article

Probiotic Amelioration of Azotemia in 5/6th Nephrectomized Sprague-Dawley Rats

1Kibow Biotech Inc., 3701 Market Street, Philadelphia, PA 19104, USA
2Department of Medicine, Division of Nephrology, Thomas Jefferson University, 1020 Locust Street, Room 353, Philadelphia, PA 19107-6799, USA
3Downstate Medical Center, State University of New York (SUNY) 450 Clarkson Avenue, Box 52, Brooklyn, NY 11203, USA

Received 26 May 2005; Revised 12 August 2005; Accepted 24 August 2005

Copyright © 2005 Natarajan Ranganathan et al.

Citations to this Article [37 citations]

The following is the list of published articles that have cited the current article.

  • Natarajan Ranganathan, Eli A. Friedman, Paul Tam, Venkat Rao, Parimalam Ranganathan, and Rahul Dheer, “Probiotic dietary supplementation in patients with stage 3 and 4 chronic kidney disease: a 6-month pilot scale trial in Canada,” Current Medical Research And Opinion, vol. 25, no. 8, pp. 1919–1930, 2009. View at Publisher · View at Google Scholar
  • Susan G. Wynn, “Probiotics in veterinary practice,” Javma-Journal Of The American Veterinary Medical Association, vol. 234, no. 5, pp. 606–613, 2009. View at Publisher · View at Google Scholar
  • Natarajan Ranganathan, Pari Ranganathan, Eli A. Friedman, Anthony Joseph, Barbara Delano, David S. Goldfarb, Paul Tam, A. Venketeshwer Rao, Emmanuel Anteyi, and Carlos Guido Musso, “Warfarin therapy in patients with venous thromboembolism: Patterns of use and predictors of clinical outcomes,” Advances In Therapy, vol. 27, no. 9, pp. 634–647, 2010. View at Publisher · View at Google Scholar
  • Natarajan Ranganathan, Pari Ranganathan, Eli A. Friedman, Anthony Joseph, Barbara Delano, David S. Goldfarb, Paul Tam, A. Venketeshwer Rao, Emmanuel Anteyi, and Carlos Guido Musso, “Pilot study of probiotic dietary supplementation for promoting healthy kidney function in patients with chronic kidney disease,” Advances in Therapy, vol. 27, no. 9, pp. 634–647, 2010. View at Publisher · View at Google Scholar
  • Edward Ramsay, Juergen Schumacher, Matthew C. Allender, and Stephanie McCain, “The Effects Of A Probiotic On Blood Urea Nitrogen And Creatinine Concentrations In Large Feuds,” Journal Of Zoo And Wildlife Medicine, vol. 42, no. 3, pp. 426–429, 2011. View at Publisher · View at Google Scholar
  • Mark Rishniw, and Susan G. Wynn, “Azodyl, a synbiotic, fails to alter azotemia in cats with chronic kidney disease when sprinkled onto food,” Journal Of Feline Medicine And Surgery, vol. 13, no. 6, pp. 405–409, 2011. View at Publisher · View at Google Scholar
  • Usha Vyas, and Natarajan Ranganathan, “Probiotics, prebiotics, and synbiotics: Gut and beyond,” Gastroenterology Research and Practice, 2012. View at Publisher · View at Google Scholar
  • Alessandro Cerbo, Federica Pezzuto, Lucia Palmieri, Valentina Rottigni, Tommaso Iannitti, and Beniamino Palmieri, “Clinical and experimental use of probiotic formulations for management of end-stage renal disease: an update,” International Urology and Nephrology, 2013. View at Publisher · View at Google Scholar
  • Luis Vitetta, and Glenda Gobe, “Uremia and chronic kidney disease: The role of the gut microflora and therapies with pro- and prebiotics,” Molecular Nutrition & Food Research, vol. 57, no. 5, pp. 824–832, 2013. View at Publisher · View at Google Scholar
  • Denise Mafra, Amanda F Barros, and Denis Fouque, “Dietary protein metabolism by gut microbiota and its consequences for chronic kidney disease patients,” Future Microbiology, vol. 8, no. 10, pp. 1317–1323, 2013. View at Publisher · View at Google Scholar
  • Arpita Mandal, Koushik Das, Suchismita Roy, Keshab Ch Mondal, and Dilip Kumar Nandi, “In vivo assessment of bacteriotherapy on acetaminophen-induced uremic rats,” Journal of Nephrology, vol. 26, no. 1, pp. 228–236, 2013. View at Publisher · View at Google Scholar
  • Ali Ramezani, “The Gut Microbiome, Kidney Disease, and Targeted Interventions,” Journal of The American Society of Nephrology, vol. 25, no. 4, pp. 657–670, 2014. View at Publisher · View at Google Scholar
  • Arpita Mandal, Arpita Patra, Shreya Mandal, Suchismita Roy, Shreya Das Mahapatra, Tapasi Das Mahapatra, Tanmay Paul, Koushik Das, Keshab Chandra Mondal, and Dilip Kumar Nandi, “Therapeutic potential of different commercially available synbiotic on acetaminophen-induced uremic rats,” Clinical and Experimental Nephrology, 2014. View at Publisher · View at Google Scholar
  • Arpita Patra, Arpita Mandal, Suchismita Roy, Shreya Mandal, Keshab Chandra Mondal, and Dilip Kumar Nandi, “Protective effect of selected urease positive Lactobacillus strains on acetaminophen induced uremia in rats,” Biomedicine & Preventive Nutrition, 2014. View at Publisher · View at Google Scholar
  • Denise Mafra, Julie C Lobo, Amanda F Barros, Laetitia Koppe, Nosratola D Vaziri, and Denis Fouque, “Role of altered intestinal microbiota in systemic inflammation and cardiovascular disease in chronic kidney disease,” Future Microbiology, vol. 9, no. 3, pp. 399–410, 2014. View at Publisher · View at Google Scholar
  • Milena Barcza Stockler-Pinto, Denis Fouque, Christophe O. Soulage, Marine Croze, and Denise Mafra, “Indoxyl Sulfate and p-Cresyl Sulfate in Chronic Kidney Disease. Could These Toxins Modulate the Antioxidant Nrf2-Keap1 Pathway?,” Journal of Renal Nutrition, 2014. View at Publisher · View at Google Scholar
  • Ranganathan Natarajan, Bohdan Pechenyak, Usha Vyas, Pari Ranganathan, Alan Weinberg, Peter Liang, Mary C. Mallappallil, Allen J. Norin, Eli A. Friedman, and Subodh J. Saggi, “Randomized Controlled Trial of Strain-Specific Probiotic Formulation (Renadyl) in Dialysis Patients,” BioMed Research International, vol. 2014, pp. 1–9, 2014. View at Publisher · View at Google Scholar
  • Eustacchio Montemurno, Carmela Cosola, Giuseppe Dalfino, Giuseppe Daidone, Maria De Angelis, Marco Gobbetti, and Loreto Gesualdo, “What Would You Like to Eat, Mr CKD Microbiota? A Mediterranean Diet, please!,” Kidney & Blood Pressure Research, vol. 39, no. 2-3, pp. 114–123, 2014. View at Publisher · View at Google Scholar
  • Laetitia Koppe, Denise Mafra, and Denis Fouque, “Probiotics and chronic kidney disease,” Kidney International, 2015. View at Publisher · View at Google Scholar
  • Leila Bouhafs, Elara N. Moudilou, Jean Marie Exbrayat, Mesbah Lahouel, and Tayeb Idoui, “ Protective effects of probiotic Lactobacillus plantarum BJ0021 on liver and kidney oxidative stress and apoptosis induced by endosulfan in pregnant rats ,” Renal Failure, vol. 37, no. 8, pp. 1370–1378, 2015. View at Publisher · View at Google Scholar
  • Amanda F Barros, Natália A Borges, Dennis C Ferreira, Flávia L Carmo, Alexandre S Rosado, Denis Fouque, and Denise Mafra, “Is there interaction between gut microbial profile and cardiovascular risk in chronic kidney disease patients?,” Future Microbiology, vol. 10, no. 4, pp. 517–526, 2015. View at Publisher · View at Google Scholar
  • R. Vanholder, and G. Glorieux, “The intestine and the kidneys: a bad marriage can be hazardous,” Clinical Kidney Journal, 2015. View at Publisher · View at Google Scholar
  • Ayumi Yoshifuji, Shu Wakino, Junichiro Irie, Takaya Tajima, Kazuhiro Hasegawa, Takeshi Kanda, Hirobumi Tokuyama, Koichi Hayashi, and Hiroshi Itoh, “ Gut Lactobacillus protects against the progression of renal damage by modulating the gut environment in rats ,” Nephrology Dialysis Transplantation, vol. 31, no. 3, pp. 401–412, 2015. View at Publisher · View at Google Scholar
  • W. H. Wilson Tang, Zeneng Wang, David J. Kennedy, Yuping Wu, Jennifer A. Buffa, Brendan Agatisa-Boyle, Xinmin S. Li, Bruce S. Levison, and Stanley L. Hazen, “Gut Microbiota-Dependent Trimethylamine N-Oxide (TMAO) Pathway Contributes to Both Development of Renal Insufficiency and Mortality Risk in Chronic Ki,” Circulation Research, vol. 116, no. 3, pp. 448–455, 2015. View at Publisher · View at Google Scholar
  • Tawfik Khoury, Keren Tzukert, Roy Abel, Ayman Abu Rmeileh, Ronen Levi, and Yaron Ilan, “The gut-kidney axis in chronic renal failure: A new potential target for therapy,” Hemodialysis International, 2016. View at Publisher · View at Google Scholar
  • R.X. Lan, J.M. Koo, and I.H. Kim, “Effects of Lactobacillus acidophilus supplementation in different energy and nutrient density diets on growth performance, nutrient digestibility, blood characteristics, fecal microbiota shedding, and fecal noxious gas emission in weaning pigs,” Animal Feed Science and Technology, 2016. View at Publisher · View at Google Scholar
  • Anitha Nallu, Shailendra Sharma, Ali Ramezani, Jagadeesan Muralidharan, and Dominic Raj, “Gut Microbiome in CKD: challenges and opportunities,” Translational Research, 2016. View at Publisher · View at Google Scholar
  • Cristiane Moraes, Natália A. Borges, and Denise Mafra, “Resistant starch for modulation of gut microbiota: Promising adjuvant therapy for chronic kidney disease patients?,” European Journal of Nutrition, 2016. View at Publisher · View at Google Scholar
  • B. Sampaio-Maia, L. Simões-Silva, M. Pestana, R. Araujo, and I.J. Soares-Silva, “The Role of the Gut Microbiome on Chronic Kidney Disease,” 2016. View at Publisher · View at Google Scholar
  • Wei Pan, and Yongbo Kang, “Gut microbiota and chronic kidney disease: implications for novel mechanistic insights and therapeutic strategies,” International Urology and Nephrology, 2017. View at Publisher · View at Google Scholar
  • Mohammadreza Ardalan, and Sepideh Zununi Vahed, “Gut microbiota and renal transplant outcome,” Biomedicine & Pharmacotherapy, vol. 90, pp. 229–236, 2017. View at Publisher · View at Google Scholar
  • Raymond Vanholder, Tessa Gryp, and Griet Glorieux, “Urea and chronic kidney disease: the comeback of the century? (in uraemia research),” Nephrology Dialysis Transplantation, 2017. View at Publisher · View at Google Scholar
  • Simona Mihai, Elena Codrici, Ionela Daniela Popescu, Ana-Maria Enciu, Lucian Albulescu, Laura Georgiana Necula, Cristina Mambet, Gabriela Anton, and Cristiana Tanase, “Inflammation-Related Mechanisms in Chronic Kidney Disease Prediction, Progression, and Outcome,” Journal of Immunology Research, vol. 2018, pp. 1–16, 2018. View at Publisher · View at Google Scholar
  • Charat Thongprayoon, Wisit Kaewput, Spencer T. Hatch, Tarun Bathini, Konika Sharma, Karn Wijarnpreecha, Patompong Ungprasert, Matthew D’Costa, Michael A. Mao, and Wisit Cheungpasitporn, “Effects of Probiotics on Inflammation and Uremic Toxins Among Patients on Dialysis: A Systematic Review and Meta-Analysis,” Digestive Diseases and Sciences, 2018. View at Publisher · View at Google Scholar
  • Manuel Velasquez, Patricia Centron, Ian Barrows, Rama Dwivedi, and Dominic Raj, “Gut Microbiota and Cardiovascular Uremic Toxicities,” Toxins, vol. 10, no. 7, pp. 287, 2018. View at Publisher · View at Google Scholar
  • Papanna Shobharani, Serva P Muthukumar, Dhanya Kizhakayil, and Prakash M Halami, “Strain-Specific Quantification of Native Probiotic Bacillus spp. and Their Effect on Liver Function and Gut Microflora of Experimental Rats,” Probiotics and Antimicrobial Proteins, 2018. View at Publisher · View at Google Scholar
  • Marinaldo Pacífico Cavalcanti Neto, Jailane de Souza Aquino, Larissa de Fátima Romão da Silva, Ruanniere de Oliveira Silva, Keyth Sulamitta de Lima Guimarães, Yohanna de Oliveira, Evandro Leite de Souza, Marciane Magnani, Hubert Vidal, and José Luiz de Brito Alves, “Gut microbiota and probiotics intervention: A potential therapeutic target for management of cardiometabolic disorders and chronic kidney disease?,” Pharmacological Research, 2018. View at Publisher · View at Google Scholar